Clinical Trial Update: Randomized Trial of Mosapride Versus Placebo in the Treatment of Constipation-Predominant Irritable Bowel Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing mosapride to placebo for constipation-predominant irritable bowel syndrome was terminated, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome Constipation Predominant

Drugs mentioned

• Mosapride (mosapride)

Snippet

Sponsor: American University of Beirut Medical Center | Conditions: Constipation-Predominant Irritable Bowel Syndrome | Phase 3 | Status: TERMINATED | Results posted: 2013-04-09